COGT
Price
$14.15
Change
+$0.86 (+6.47%)
Updated
Sep 26, 04:59 PM (EDT)
Capitalization
1.98B
51 days until earnings call
ZIVO
Price
$13.91
Change
+$0.91 (+7.00%)
Updated
Sep 25 closing price
Capitalization
53.09M
Interact to see
Advertisement

COGT vs ZIVO

Header iconCOGT vs ZIVO Comparison
Open Charts COGT vs ZIVOBanner chart's image
Cogent Biosciences
Price$14.15
Change+$0.86 (+6.47%)
Volume$54.68K
Capitalization1.98B
Zivo Bioscience
Price$13.91
Change+$0.91 (+7.00%)
Volume$110
Capitalization53.09M
COGT vs ZIVO Comparison Chart in %
Loading...
COGT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ZIVO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
COGT vs. ZIVO commentary
Sep 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is COGT is a StrongBuy and ZIVO is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 27, 2025
Stock price -- (COGT: $14.16 vs. ZIVO: $13.91)
Brand notoriety: COGT and ZIVO are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: COGT: 184% vs. ZIVO: 9%
Market capitalization -- COGT: $1.98B vs. ZIVO: $53.09M
COGT [@Biotechnology] is valued at $1.98B. ZIVO’s [@Biotechnology] market capitalization is $53.09M. The market cap for tickers in the [@Biotechnology] industry ranges from $98.9B to $0. The average market capitalization across the [@Biotechnology] industry is $1.9B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

COGT’s FA Score shows that 0 FA rating(s) are green whileZIVO’s FA Score has 0 green FA rating(s).

  • COGT’s FA Score: 0 green, 5 red.
  • ZIVO’s FA Score: 0 green, 5 red.
According to our system of comparison, COGT is a better buy in the long-term than ZIVO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

COGT’s TA Score shows that 5 TA indicator(s) are bullish while ZIVO’s TA Score has 5 bullish TA indicator(s).

  • COGT’s TA Score: 5 bullish, 4 bearish.
  • ZIVO’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, both COGT and ZIVO are a good buy in the short-term.

Price Growth

COGT (@Biotechnology) experienced а +18.30% price change this week, while ZIVO (@Biotechnology) price change was +6.92% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.00%. For the same industry, the average monthly price growth was +9.18%, and the average quarterly price growth was +54.60%.

Reported Earning Dates

COGT is expected to report earnings on Nov 17, 2025.

Industries' Descriptions

@Biotechnology (+4.00% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
COGT($1.98B) has a higher market cap than ZIVO($53.1M). COGT YTD gains are higher at: 81.474 vs. ZIVO (-35.302). ZIVO has higher annual earnings (EBITDA): -9.7M vs. COGT (-299.34M). COGT has more cash in the bank: 238M vs. ZIVO (9.82K). ZIVO has less debt than COGT: ZIVO (779K) vs COGT (60.7M). ZIVO has higher revenues than COGT: ZIVO (175K) vs COGT (0).
COGTZIVOCOGT / ZIVO
Capitalization1.98B53.1M3,725%
EBITDA-299.34M-9.7M3,087%
Gain YTD81.474-35.302-231%
P/E RatioN/AN/A-
Revenue0175K-
Total Cash238M9.82K2,422,885%
Total Debt60.7M779K7,792%
FUNDAMENTALS RATINGS
COGT vs ZIVO: Fundamental Ratings
COGT
ZIVO
OUTLOOK RATING
1..100
119
VALUATION
overvalued / fair valued / undervalued
1..100
87
Overvalued
78
Overvalued
PROFIT vs RISK RATING
1..100
85100
SMR RATING
1..100
100100
PRICE GROWTH RATING
1..100
3791
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
5036

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ZIVO's Valuation (78) in the null industry is in the same range as COGT (87) in the Miscellaneous industry. This means that ZIVO’s stock grew similarly to COGT’s over the last 12 months.

COGT's Profit vs Risk Rating (85) in the Miscellaneous industry is in the same range as ZIVO (100) in the null industry. This means that COGT’s stock grew similarly to ZIVO’s over the last 12 months.

COGT's SMR Rating (100) in the Miscellaneous industry is in the same range as ZIVO (100) in the null industry. This means that COGT’s stock grew similarly to ZIVO’s over the last 12 months.

COGT's Price Growth Rating (37) in the Miscellaneous industry is somewhat better than the same rating for ZIVO (91) in the null industry. This means that COGT’s stock grew somewhat faster than ZIVO’s over the last 12 months.

COGT's P/E Growth Rating (100) in the Miscellaneous industry is in the same range as ZIVO (100) in the null industry. This means that COGT’s stock grew similarly to ZIVO’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
COGTZIVO
RSI
ODDS (%)
N/A
Bullish Trend 3 days ago
81%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
83%
Bullish Trend 3 days ago
75%
Momentum
ODDS (%)
Bullish Trend 3 days ago
82%
Bullish Trend 3 days ago
74%
MACD
ODDS (%)
Bullish Trend 3 days ago
83%
Bearish Trend 3 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
84%
Bullish Trend 3 days ago
73%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
83%
Bearish Trend 3 days ago
90%
Advances
ODDS (%)
Bullish Trend 3 days ago
83%
N/A
Declines
ODDS (%)
Bearish Trend 13 days ago
83%
Bearish Trend 23 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
87%
Bullish Trend 3 days ago
81%
Aroon
ODDS (%)
Bullish Trend 3 days ago
80%
Bearish Trend 3 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
COGT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ZIVO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
HRLFX9.67N/A
N/A
Hartford Real Asset F
FCGCX21.17N/A
N/A
Fidelity Advisor Global Commodity Stk C
CHCCX4.17N/A
N/A
AB Discovery Growth C
AGRDX68.65N/A
N/A
American Century Growth R6
MVGMX18.33N/A
N/A
MFS Low Volatility Global Equity R4

COGT and

Correlation & Price change

A.I.dvisor indicates that over the last year, COGT has been loosely correlated with HOFBF. These tickers have moved in lockstep 63% of the time. This A.I.-generated data suggests there is some statistical probability that if COGT jumps, then HOFBF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To COGT
1D Price
Change %
COGT100%
+6.51%
HOFBF - COGT
63%
Loosely correlated
N/A
TNFA - COGT
55%
Loosely correlated
N/A
NUVL - COGT
51%
Loosely correlated
+4.99%
ATXS - COGT
50%
Loosely correlated
+2.10%
IMVT - COGT
50%
Loosely correlated
+3.51%
More

ZIVO and

Correlation & Price change

A.I.dvisor tells us that ZIVO and MDXXF have been poorly correlated (+22% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ZIVO and MDXXF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ZIVO
1D Price
Change %
ZIVO100%
N/A
MDXXF - ZIVO
22%
Poorly correlated
-2.18%
ATXS - ZIVO
21%
Poorly correlated
+2.10%
COGT - ZIVO
20%
Poorly correlated
+6.55%
CLSD - ZIVO
20%
Poorly correlated
+8.31%
ATHA - ZIVO
15%
Poorly correlated
+1.31%
More